Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Bobardt

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Virology|February 12, 2002
trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activityAndrew C S Saphire, Michael D Bobardt, Philippe A Gallay
Journal of Virology|April 5, 2002
Cyclophilin a plays distinct roles in human immunodeficiency virus type 1 entry and postentry events, as revealed by spinoculationAndrew C S Saphire, Michael D Bobardt, Philippe A Gallay
The Journal of General Virology|January 29, 2010
Cyclophilin A-independent recruitment of NS5A and NS5B into hepatitis C virus replication complexesUdayan Chatterji, Michael D Bobardt, Precious Lim, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2010
Syndecan-Fc hybrid molecule as a potent in vitro microbicidal anti-HIV-1 agentMichael D Bobardt, Udayan Chatterji, Lana Schaffer, et al.
Plos One|April 23, 2016
Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175Philippe A Gallay, Udayan Chatterji, Michael D Bobardt, et al.
The Journal of Biological Chemistry|October 10, 2006
Trim5alpha accelerates degradation of cytosolic capsid associated with productive HIV-1 entryUdayan Chatterji, Michael D Bobardt, Peter Gaskill, et al.
Plos One|February 18, 2014
HCV core residues critical for infectivity are also involved in core-NS5A complex formationKatarzyna Gawlik, James Baugh, Udayan Chatterji, et al.
Pharmaceutical Research|June 28, 2012
Sustained local delivery of structurally diverse HIV-1 microbicides released from sublimation enthalpy controlled matricesSimi Gunaseelan, Philippe A Gallay, Michael D Bobardt, et al.
Viruses|March 26, 2013
Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphismsPhilippe A Gallay, Roger G Ptak, Michael D Bobardt, et al.
Plos One|August 12, 2015
The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of ActionPhilippe A Gallay, Michael D Bobardt, Udayan Chatterji, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Virology|February 12, 2002
trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activityAndrew C S Saphire, Michael D Bobardt, Philippe A Gallay
Journal of Virology|April 5, 2002
Cyclophilin a plays distinct roles in human immunodeficiency virus type 1 entry and postentry events, as revealed by spinoculationAndrew C S Saphire, Michael D Bobardt, Philippe A Gallay
The Journal of General Virology|January 29, 2010
Cyclophilin A-independent recruitment of NS5A and NS5B into hepatitis C virus replication complexesUdayan Chatterji, Michael D Bobardt, Precious Lim, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2010
Syndecan-Fc hybrid molecule as a potent in vitro microbicidal anti-HIV-1 agentMichael D Bobardt, Udayan Chatterji, Lana Schaffer, et al.
Plos One|April 23, 2016
Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175Philippe A Gallay, Udayan Chatterji, Michael D Bobardt, et al.
The Journal of Biological Chemistry|October 10, 2006
Trim5alpha accelerates degradation of cytosolic capsid associated with productive HIV-1 entryUdayan Chatterji, Michael D Bobardt, Peter Gaskill, et al.
Plos One|February 18, 2014
HCV core residues critical for infectivity are also involved in core-NS5A complex formationKatarzyna Gawlik, James Baugh, Udayan Chatterji, et al.
Pharmaceutical Research|June 28, 2012
Sustained local delivery of structurally diverse HIV-1 microbicides released from sublimation enthalpy controlled matricesSimi Gunaseelan, Philippe A Gallay, Michael D Bobardt, et al.
Viruses|March 26, 2013
Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphismsPhilippe A Gallay, Roger G Ptak, Michael D Bobardt, et al.
Plos One|August 12, 2015
The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of ActionPhilippe A Gallay, Michael D Bobardt, Udayan Chatterji, et al.
Pageof 3